Search results for "Vaginal Disease"

showing 2 items of 12 documents

Efficacy and tolerability of a plant-based, multi-component cream (Ginetrox®) in vulvovaginal disorders of the genitourinary syndrome during menopaus…

2017

BACKGROUND Genitourinary syndrome of menopause (GSM) is a symptomatic condition including vaginal dryness, irritation, dyspareunia and recurrent urinary tract infections which affects 40-54% of post-menopausal women. Although several estrogen-based therapies are available, it is generally preferable to avoid hormonal therapy, particularly in women with mild symptoms or at risk for estrogen-responsive neoplasia. Therefore, the most common treatment options are over-the-counter vaginal creams for symptomatic relief. METHODS Thirty-three postmenopausal women suffering from GSM were enrolled in this observational study. A multi-component cream (Ginetrox®, Indena, Milan, Italy) was applied on th…

medicine.medical_specialtyVisual analogue scaleVaginal DiseasesPainmedicine.disease_causeMedication AdherenceInternal medicinemedicineHumansAgedbusiness.industryGenitourinary systemObstetrics and GynecologySyndromeMiddle Agedmedicine.diseaseSymptomatic reliefMenopauseAdministration Intravaginalmedicine.anatomical_structureDyspareuniaTreatment OutcomeTolerabilityItalyVaginaVaginal Creams Foams and JelliesHormonal therapyFemalePlant PreparationsVulvar DiseasesIrritationMenopausebusinessMinerva ginecologica
researchProduct

Vulvo-vaginal atrophy: A new treatment modality using thermo-ablative fractional CO2 laser.

2015

a b s t r a c t Objective: To evaluate the efficacy and feasibility of thermo-ablative fractional CO2 laser for the treatment of symptoms related to vulvo-vaginal atrophy (VVA) in post-menopausal women. Methods: From April 2013 to December 2013, post-menopausal patients who complained of one or more VVA-related symptoms and who underwent vaginal treatment with fractional CO2 laser were enrolled in the study. At baseline (T0) and 30 days post-treatment (T1), vaginal status of the women was evaluated using the Vaginal Health Index (VHI), and subjective intensity of VVA symptoms was evaluated using a visual analog scale (VAS). At T1, treatment satisfaction was evaluated using a 5-point Likert …

medicine.medical_specialtyVisual analogue scaleVaginal DiseasesPilot ProjectsGeneral Biochemistry Genetics and Molecular BiologyVulvaAtrophyQuality of lifeLaser treatmentAblative casemedicineHumansAdverse effectbusiness.industryObstetrics and GynecologyMiddle Agedmedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaSurgeryMenopausePostmenopauseAdministration IntravaginalDyspareuniaTreatment OutcomeLasers GasQuality of LifeItchingFemaleVaginal atrophyLaser Therapymedicine.symptomAtrophyMenopausebusinessVulvo-vaginal atrophy
researchProduct